Beta-Neoendorphin

Beta-neoendorphin is a nine-residue opioid peptide from prodynorphin, closely related to α-neoendorphin and dynorphin B. The pair illustrates how a single precursor is sliced into a panel of subtly different κ-receptor messages.

Chemical Class
Opioid peptide (9 aa, from prodynorphin)
Source
Prodynorphin neurons — hypothalamus, spinal cord, pituitary
Primary Targets
κ/δ opioid receptor fields
Receptor
κ-opioid receptor, δ

Production & Clearance

The reviewed human PDYN record maps α-neoendorphin to precursor residues 175–184 and β-neoendorphin to 175–183. Thus the two peptides differ by one terminal lysine, rather than being two ten-residue sequences. Both begin with the five-residue Leu-enkephalin motif. These coordinates identify the molecules directly and distinguish their sequences from the longer dynorphin peptides produced elsewhere in the same precursor.

Mechanism of Action

κ-preferring agonism with mixed κ/δ affinity — the canonical opioid Gi/o inhibition of transmitter release (opioid receptors, signaling). The pharmacological differences between α- and β-neoendorphin are subtle: same address, slightly different key.

Physiological Effects

Interactions & Feedback

The family relationship does not make the individual peptides interchangeable. A study of the combined dynorphin–κ-receptor system can establish a circuit-level effect without identifying which processed peptide supplied it. Sequence-specific measurements and receptor assays are therefore needed when attributing a particular effect to one neoendorphin. This matters when comparing tissue extracts, precursor-gene expression and experiments using a single synthetic peptide.

When It Goes Wrong

Sources